1. A randomised, double-blind, placebo controlled , dose ranging study of the safety and efficacy of tolterodine in patients with hyperreflexia;Abrams,1996
2. Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder;Abrams;British Journal of Urology,1998
3. Efficacy and tolerability of tolterodine vs. oxybutynin and placebo in patients with detrusor instability;Abrams,1997
4. Tolterodine treatment is safe in men with bladder outlet obstruction (BOO) and symptomatic detrusor overactivity (DO);Abrams,2001
5. Trospium chloride (Spasmo-lyt) in patients with motor urge syndrome (detrusor instability): a double-blind, randomised, multicentre, placebo-controlled study;Alloussi;Journal of Clinical Research,1998